Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur Heart J. 2017 Mar 14; 38(11):804-810.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Cause of Death
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hemorrhage
Humans
Lactones
Male
Middle Aged
Non-ST Elevated Myocardial Infarction
Platelet Aggregation Inhibitors
Pyridines
Receptors, Thrombin

authors with profiles

Robert Harrington